How Do Molecular Factors Impact Response to Immunotherapy in Kidney Cancer?
Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.
Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.
Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment.
Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has returned.
Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission following second-line salvage therapy.
In the INNOVATION trial, adding Herceptin and Perjeta to chemotherapy increased toxicity in patients with HER2-positive gastric cancers.
Restorative reflection is an important approach for nurses, says Dr Sarah Bekaert
A lack of essential vitamins and minerals is common in people with type 2 diabetes, a new study has found.
Commentary on: Alkan, E., Cushen-Brewster, N. & Anyanwu, P. Organisational factors associated with healthcare workforce development, recruitment, and retention in the United Kingdom: a systematic…
After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with confidence and self-advocacy.
Read about why community nurses working rurally have praised a new digital system which has been rolled out across Northern Ireland.
As the government plans to include practice nurses in the ARRS, we explore the negative effect of the scheme